<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a case of immune-mediated <z:hpo ids='HP_0002196'>myelopathy</z:hpo> occurring 4 months after unrelated bone marrow transplantation for <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>After the tapering of <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> for <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> prophylaxis, the patient developed several neurological symptoms mimicking the clinical features of multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> (MS) </plain></SENT>
<SENT sid="2" pm="."><plain>Although neurological exacerbation was well stabilized with a bulk dose of <z:chebi fb="0" ids="50858">corticosteroid</z:chebi>, sustained improvement of neurological deficits occurred after the patient developed hematopoietic mixed chimerism (HMC) </plain></SENT>
<SENT sid="3" pm="."><plain>This experience may provide clinical evidence supporting the current therapeutic concept, in which HMC induction can potentially cure several <z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune diseases</z:e>, including MS </plain></SENT>
</text></document>